The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Fiducial-less stereotactic radiotherapy for early-stage lung cancer: Efficacy and toxicity evaluation.
J. Bibault
No relevant relationships to disclose
B. Prevost
No relevant relationships to disclose
E. Dansin
No relevant relationships to disclose
X. Mirabel
No relevant relationships to disclose
T. Lacornerie
No relevant relationships to disclose
F. Dubus
No relevant relationships to disclose
E. Lartigau
No relevant relationships to disclose